Figure 4

Survival curves of different risk scores in subcohorts. (A) Gender, (B) Age, (C) Histologic grade, (D) T stage, (E) Lymphatic metastasis, (F) Clinical stage; the correlation analysis revealed that stage III/IV and T3/4 patients exhibited an elevated risk score in contrast with the stage I/II and T1/2 patients (G).